Ziosoft Launches Innovative Plaque Analysis Feature in REVORAS Software at RSNA Conference
NEWARK, Calif., December 2, 2025 — Ziosoft, a recognized leader in advanced visualization and artificial intelligence applications, has introduced a groundbreaking plaque analysis feature as part of its REVORAS software platform at the annual Radiology Society of North America (RSNA) conference in Chicago, running from November 30 to December 3, 2025. This feature, pending FDA clearance, allows healthcare providers to conduct detailed coronary plaque assessments in-house for research purposes.
The REVORAS platform represents a significant advancement in cardiovascular and surgical imaging, according to Rajeev Taitriya, Ziosoft’s Vice President of Business Development and Marketing. “We have created a unified environment that integrates CT and MRI imaging to improve patient care,” Taitriya explained. The platform aims to facilitate real-time plaque analysis and surgical planning, enhancing efficiency while minimizing costs and ensuring data security.
Key benefits of the REVORAS Plaque Analysis feature include:
- On-Site Analysis: Allows healthcare organizations to execute comprehensive cardiac evaluations within their facilities, decreasing reliance on external services, and safeguarding sensitive patient information.
- Faster Decision-Making: Rapid on-site processing enables clinicians to make timely, informed decisions about patient care.
- Advanced Characterization: The tool differentiates plaque types—such as calcified and necrotic-core—offering critical insights for patient-specific treatment plans.
Moreover, the platform extends its capabilities beyond diagnostics through the introduction of a surgical imaging suite that supports various surgical procedures, including lung and liver resections. This initiative enhances collaboration between radiology and surgical teams, ultimately improving patient outcomes.
Ziosoft’s REVORAS solutions are available through ZioFlex, a subscription model designed to eliminate capital barriers and facilitate scalability for healthcare providers. “With ZioFlex, customers can adopt technological innovations that fit their needs without compromise,” Taitriya stated, emphasizing the importance of robust partnerships across medical disciplines.
In addition to the plaque analysis feature, Ziosoft is also showcasing Atrena, an imaging viewer software on the REVORAS platform, which enhances 3D stereoscopic viewing capabilities.
Founded in 1998, Ziosoft operates globally, with thousands of installations across over 30 countries, enabling improved diagnostic accuracy and treatment planning through vendor-neutral, multi-modality imaging technology. For more details, visit Ziosoft’s official website.
